| USAN |
Research Code |
InChIKey (Parent) |
Drug Class |
Therapeutic class |
Target |
| aducanumab |
BIIB-037 |
n/a |
monoclonal antibody |
therapeutic |
beta amyloid |
| aptorsen-sodium |
OGX-427 |
n/a |
oligonucleotide |
therapeutic |
HSP27 |
| asfotase-alfa |
ALXN-1215, ENB-0040 |
n/a |
enzyme |
therapeutic |
n/a |
| batefenterol, batefenterol-succinate |
GSK-961081A |
URWYQGVSPQJGGB-DHUJRADRSA-N |
synthetic small molecule |
therapeutic |
Muscarinic receptors, B2 receptor |
| bococizumab |
RN-316, PF-04950615 |
n/a |
monoclonal antibody |
therapeutic |
PC9 |
| dactolisib, dactolisib-tosylate |
NVP-BEZ235-NX
|
JOGKUKXHTYWRGZ-UHFFFAOYSA-N |
synthetic small molecule |
therapeutic |
MTOR, PI3K |
| deldeprevir, deldeprevir-sodium |
ACH-0142684, ACH-2684 |
UDMJANYPQWEDFT-ZAWFUYGJSA-N |
synthetic small molecule |
therapeutic |
HCV NS3 PR |
| etiguanfacine |
SSP-1871 |
NWKJFUNUXVXYGE-UHFFFAOYSA-N |
synthetic small molecule |
therapeutic |
|
| faldaprevir, faldaprevir-sodium |
BI-201335 |
|
synthetic small molecule |
therapeutic |
HCV NS3 PR |
| fedratinib |
SAR-302503; TG-101348 |
JOOXLOJCABQBSG-UHFFFAOYSA-N |
synthetic small molecule |
therapeutic |
FLT3, JAK2 |
| grazoprevir |
n/a |
n/a |
synthetic small molecule |
therapeutic |
|
| irinotecan-sucrosofate |
MM-398, PEP-02 |
n/a |
natural product derived small molecule |
therapeutic |
topo 1 |
| luspatercept |
ACE-536 |
n/a |
protein |
therapeutic |
TGF-B family |
| mavoglurant |
AFQ-056 |
ZFPZEYHRWGMJCV-ZHALLVOQSA-N |
synthetic small molecule |
therapeutic |
mGluR5 |
| otlertuzumab |
TRU-016 |
n/a |
monoclonal antibody |
therapeutic |
CD37 |
| ralpancizumab |
RN317, PF-05335810 |
n/a |
monoclonal antibody |
therapeutic |
PC9 |
| romyelocel-l |
CLT-008 |
n/a |
cellular therapy |
therapeutic |
n/a |
| roxadustat |
FG-4592; ASP-1517 |
YOZBGTLTNGAVFU-UHFFFAOYSA-N |
synthetic small molecule |
therapeutic |
prolyl hydoxylase |
| simtuzumab |
AB-0024; GS-6624 |
n/a |
monoclonal antibody |
therapeutic |
LOXL2 |
| sucroferric-oxyhydroxide |
PA-21 |
n/a |
inorganic |
sequestering agent |
n/a |
| tecemotide |
BLP-25 |
n/a |
peptide vaccine |
peptide vaccine |
n/a |
